Abstracts
Deadline: October 2nd, 2023 at 11:59 PM EST
If you have any questions about abstract submission, please email us at info@hepdart.com.
All accepted abstracts will be made available to conference delegates through the abstract booklet, available on the website, and in print on December 3, 2023.
Guidelines
Use Arial font size 10 for your abstract
Please include a title in bold at the top of the abstract, this should be followed by list of authors and affiliations
All submitted abstracts should consist of background, methods, results, and conclusions
All text should flush to the left side of the page
Although there is no word limit to the abstract, we recommend a length of 500 words
If you choose to include figures, tables, or chemical structures in your abstract, please fit the abstract to one page (A4)
Please see below for an example of an abstract
Categories for abstract submission
Global hepatitis epidemiology and prospects for elimination
Access, cost, and treatment in special populations
Hepatitis B basic science
Advances in therapeutics for HBV
Curative strategies for HBV
Clinical advancements for HBV
COVID-19 and liver disease
Advances in therapeutics for NASH/NAFLD and HCC
New developments in liver disease, NASH and biomarkers
Diagnostics
Advances in HCV therapy
Advances in therapeutics for HDV
Immunity, vaccines and transplantation
Hepatocellular carcinoma: New treatments and findings
Hepatitis A, hepatitis E and other hepatitis viruses
Viral hepatitis and co-infections with HIV and other viruses
Powerpoint Slides
There is not a template for slides, but we recommend a 16:9 widescreen format for best results.
Late Breaker Abstract Deadline: Monday, November 20, 2023 5:00 PM EST
Late breaker abstracts should present data that are high impact, ground-breaking and innovative. This submission should not be used as a mechanism for submitting updated data for abstracts that were available by the general deadline.